DATATRAK International, Inc. : DATATRAK to Present at the OneMedForum
January 04, 2012 at 08:17 am
By
Share
CLEVELAND, [January 4th] /PRNewswire/ - DATATRAK
International, Inc. (OTCQX: DATA), a technology and
services company focused on global eClinical solutions for
the clinical trials industry, today announced that Laurence
P. Birch, DATATRAK's Chairman and CEO, has been invited to
present at the OneMedForum in San Francisco on Tuesday
January 10, 2012. DATATRAK's presentation is scheduled for
2:30 PM PST in the Windsor room of the Sir Francis Drake
Hotel with a breakout session to follow on the 18th floor.
The presentation will be broadcast live via the web site.
About OneMedForum
OneMedForum San Francisco 2012 runs concurrently with the
J.P. Morgan conference and provides efficient access to the
companies that shape the future of the rapidly changing
healthcare landscape. The forum is designed to create a
communications platform for emerging companies to connect
with strategic partners and investors.
About DATATRAK
DATATRAK International is a worldwide technology and
services company delivering eClinical solutions and related
services for the clinical trials industry. DATATRAK built
its multi-component, comprehensive solution on a single,
unified platform and expanded this concept to include
services delivery via DATATRAK's Clinical and Consulting
Services™ group. The Company delivers a complete portfolio
of software products designed to accelerate the reporting
of clinical research data from sites to sponsors and
ultimately regulatory authorities, faster and more
efficiently than loosely integrated technologies. The
DATATRAK ONE™ software solution, deployed worldwide through
an ASP or Enterprise Transfer offering, supports Phase I -
Phase IV drug and devices studies in multiple languages
throughout the world. DATATRAK has offices located in
Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North
Carolina. For more information, visit .
Except for the historical information contained in this
press release, the statements made in this release are
forward-looking statements. These forward-looking
statements are made based on management's expectations,
assumptions, estimates and current beliefs concerning the
operations, future results and prospects of the Company and
are subject to uncertainties and factors which are
difficult to predict and, in many instances, are beyond the
control of the Company, and which could cause actual
results to differ materially from those contemplated in
these forward-looking statements. For a list of certain of
the factors that may cause actual results to differ
materially from those contemplated in these forward looking
statements, please see the Company's quarterly
report filed with the OTCQX Market announcing its results
for the three-month period ending September 30, 2011. The
Company undertakes no obligation to update publicly or
revise any forward-looking statement whether as a result of
new information, future events or otherwise.
CONTACT:
Lisa Pahl, Director Marketing, DATATRAK International,
Inc., +1-979-393-9025
distribué par
Ce noodl a été diffusé par DataTrak International Inc. et initialement mise en ligne sur le site http://www.datatrak.net. La version originale est disponible ici.
Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-04 14:11:40 PM et restera accessible depuis ce lien permanent.
Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité.
Datatrak International, Inc. is a technology and services company. The Company is engaged in delivering global eClinical solutions for the clinical trials industry. The Company is focused on providing subscription and professional services. Its enterprise platforms include Decentralized Trials (including, electronic consent (e-Consent), electronic patient reported outcomes (e-PRO) and electronic clinical outcomes assessment (e-COA), electronic data capture, clinical trial management system (CTMS) and imaging and endpoint adjudication, randomization, and business intelligence. The Companyâs CTMS includes functions for site feasibility and the tracking of action items and milestones. Its imaging and endpoint adjudication is a streamline the approach for managing imaging components while reducing manual workload and errors. Its business intelligence offers solution to create, monitor, and analyze user research and providing insights that allow to optimize processes from all aspects.